N-methyl-D-aspartate receptor (NMDAR) glycine co-agonist site (NMDAR glycine site)

The N-methyl-D-aspartate receptor (NMDAR) glycine co-agonist site is a critical regulatory locus located on the GluN1 and GluN3 subunits of the NMDAR complex (UniProt: P05231). Unlike most ligand-gated ion channels, the NMDAR requires the simultaneous binding of two different agonists—glutamate and a co-agonist like glycine or D-serine—to open its central pore and allow cation influx (StatPearls: NMDA Receptor). This site is distinct from the inhibitory glycine receptor and is often termed the strychnine-insensitive site. Biologically, it is essential for mediating synaptic plasticity and long-term potentiation, which are the cellular foundations of learning and memory. In disease states, NMDAR hypofunction at this site is a core component of the glutamate hypothesis of schizophrenia, contributing to cognitive and negative symptoms (PubMed: 18408235). Conversely, excessive activation of the receptor can lead to calcium-induced excitotoxicity, which is implicated in stroke and neurodegenerative conditions. Pharmacological agents targeting this site include agonists and partial agonists like D-cycloserine, which are used to enhance NMDAR signaling, and antagonists like gavestinel, which have been explored for neuroprotection (PubChem: CID 784).

Other names

Strychnine-insensitive glycine binding siteGluN1 glycine siteNMDA receptor glycine siteGlycine-B siteNR1 glycine site

Drugs targeting this site act as co-agonists, partial agonists, or competitive antagonists to modulate the opening of the NMDA receptor ion channel, thereby regulating calcium and sodium influx into the neuron (StatPearls: NMDA Receptor).